格雷夫斯病治疗患者 T3 抑制试验前后血清 T3、T4 和 TSH 的变化（作者译） - Suppr | 超能文献

[Changes in serum T3, T4 and TSH before and after the T3-suppression test in patients treated for Graves' disease (author's transl)].

作者信息

Tamai H, Suematsu H, Esaki M, Kurakawa N, Aoki H

出版信息

Nihon Naibunpi Gakkai Zasshi. 1977 Jan 20;53(1):17-27. doi: 10.1507/endocrine1927.53.1_17.

DOI:10.1507/endocrine1927.53.1_17

PMID:72007

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Changes in serum T3, T4 and TSH before and after the T3-suppression test in patients treated for Graves' disease (author's transl)].格雷夫斯病治疗患者 T3 抑制试验前后血清 T3、T4 和 TSH 的变化（作者译）

Nihon Naibunpi Gakkai Zasshi. 1977 Jan 20;53(1):17-27. doi: 10.1507/endocrine1927.53.1_17.

2

Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.促甲状腺激素释放激素对血清甲状腺激素的影响：一项关于未经治疗及已治疗的格雷夫斯病和亚急性甲状腺炎患者的研究。

J Clin Endocrinol Metab. 1995 Jul;80(7):2173-7. doi: 10.1210/jcem.80.7.7608274.

3

[Serum thyroid hormones and TSH response to TRH during treatment of Graves' disease by carbimazole (author's transl)].[卡比马唑治疗格雷夫斯病期间血清甲状腺激素及TSH对促甲状腺激素释放激素的反应（作者译）]

Ann Endocrinol (Paris). 1979 Jul-Aug;40(4):441-2.

4

[Clinical studeis on the regulatory system of thyroid hormone secretion and serum triiodothyronine. Part III. Studies on thyroid hormone change and its relationship when TSH in cases with subclinical hypothyroidism (Hashimoto's thyroiditis and 131I treated Graves' disease)].甲状腺激素分泌调节系统及血清三碘甲状腺原氨酸的临床研究。第三部分。亚临床甲状腺功能减退症（桥本甲状腺炎和¹³¹I治疗的格雷夫斯病）患者促甲状腺激素时甲状腺激素变化及其关系的研究

Nihon Naibunpi Gakkai Zasshi. 1975 Feb 20;51(2):85-97. doi: 10.1507/endocrine1927.51.2_85.

5

Changes in serum TSH and T4 after T3 suppression tests in patients treated for hyperthyroidism due to Graves' disease.格雷夫斯病所致甲状腺功能亢进症患者接受 T3 抑制试验后血清促甲状腺激素（TSH）和甲状腺素（T4）的变化。

J Clin Endocrinol Metab. 1977 Nov;45(5):1013-8. doi: 10.1210/jcem-45-5-1013.

6

[Clinical studies on regulatory system of thyroid hormone secretion and serum triiodothyronine. Part II. Development of rapid radioimmunoassay for triiodothyronine (author's transl)].甲状腺激素分泌调节系统及血清三碘甲状腺原氨酸的临床研究。第二部分。三碘甲状腺原氨酸快速放射免疫测定法的建立（作者译）

Nihon Naibunpi Gakkai Zasshi. 1975 Jan 20;51(1):36-47. doi: 10.1507/endocrine1927.51.1_36.

7

Serum thyrotropin in Graves' disease: a more reliable index of circulating thyroid-stimulating immunoglobulin level than thyroid function?格雷夫斯病中的血清促甲状腺激素：相较于甲状腺功能，它是循环中甲状腺刺激免疫球蛋白水平更可靠的指标吗？

Endocr Pract. 2007 Oct;13(6):615-9. doi: 10.4158/EP.13.6.615.

8

Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.血清促甲状腺激素（TSH）水平持续受到抑制，可能归因于促甲状腺激素受体抗体活性、甲状腺毒症的严重程度以及接受治疗的甲状腺功能正常的格雷夫斯病患者甲状腺激素恢复所需的时间。

Thyroid. 2006 Dec;16(12):1251-7. doi: 10.1089/thy.2006.16.1251.

9

Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis.格雷夫斯病和亚急性甲状腺炎患者血清甲状腺球蛋白、三碘甲状腺原氨酸和甲状腺素的连续变化相关性

Metabolism. 1978 Apr;27(4):449-60. doi: 10.1016/0026-0495(78)90099-9.

10

Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease.血清三碘甲状腺原氨酸与甲状腺素的比值及以三碘甲状腺原氨酸为主的格雷夫斯病的预后

Ann Intern Med. 1984 Mar;100(3):372-5. doi: 10.7326/0003-4819-100-3-372.